Source link : https://newshealth.biz/health-news/trial-data-shed-light-on-als-clinical-research/
(MedPage Today) — The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary endpoint in amyotrophic lateral sclerosis (ALS), but its findings shed light on ALS clinical research… Source link : https://www.medpagetoday.com/neurology/generalneurology/114804 Author : Publish date : 2025-03-24 21:42:00 Copyright for syndicated content belongs to the linked […]
The post Trial Data Shed Light on ALS Clinical Research first appeared on News Health.
Author : News Health
Publish date : 2025-03-24 21:42:00
Copyright for syndicated content belongs to the linked Source.